South Dakota Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 3 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 2,664
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 24.57%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 423
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 28.40%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 72.37% 69.74%
White, Hispanic/Latino Patients 8.41% 11.11%
Black/African American, Non-Hispanic/Latino Patients 0.98% 1.65%
Black/African American, Hispanic/Latino Patients 0.11% 0.00%
Asian Patients3 2.33% 4.26%
American Indian/Alaska Native Patients3 6.01% 4.02%
Native Hawaiian/Other Pacific Islander Patients3 0.38% 0.24%
Patients with More than one race3 4.43% 4.96%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.94% 1.42%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.33% 1.18%
Unreported/Refused to Report Race and Ethnicity 1.73% 1.42%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 193
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 36.17%
COVID-19 Immunization Series Completed 241
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 37.83%
COVID-19 Immunization Series Additional 35
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 18.18%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 62.18% 59.34% 77.14%
White, Hispanic/Latino Patients 8.81% 10.37% 5.71%
Black/African American, Non-Hispanic/Latino Patients 1.04% 1.66% 0.00%
Black/African American, Hispanic/Latino Patients 1.04% 0.83% 0.00%
Asian Patients3 7.25% 10.79% 5.71%
American Indian/Alaska Native Patients3 12.44% 10.37% 5.71%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.00%
Patients with More than one race3 1.04% 1.24% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.63% 0.83% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.04% 0.00% 2.86%
Unreported/Refused to Report Race and Ethnicity 1.55% 4.56% 2.86%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 100.00%
1 to 24 Hours 0.00%
More Than 24 Hours 0.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 66.67%
Vaccine confidence 0.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 33.33%
None 0.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 96.67%
Average Percent of Health Center Visits Conducted Virtually 5.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 0.00%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 66.67%
None 33.33%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 33.33%
Other 0.00%
None 66.67%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021